Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VRDNthis companyViridian Therapeutics, Inc.	$28.80	-9.37×	3.65×	37.25×	-7.35×	-126.3%	100.0%	-512.9%	-483.6%	-47.4%	-43.8%	-10.5%	0.07×	0.48×	-73.44×	12.65×	0.0%	3	2.02	1	C-
EYPTEyePoint Pharmaceuticals, Inc.	$0.36	-5.76×	4.37×	42.66×	-5.49×	-1218.8%	93.4%	-776.0%	-739.4%	-75.8%	-74.0%	-18.2%	0.07×	0.34×	0×	8.88×	0.0%	2	-11.09	1	C-
OCULOcular Therapeutix, Inc.	$6.15	-8.55×	3.47×	43.86×	-6.47×	-101.4%	87.3%	-521.0%	-513.2%	-40.6%	-35.5%	-9.5%	0.12×	2.63×	-22.82×	15.39×	0.0%	2	2.82	1	C-
OTLKOutlook Therapeutics, Inc.	$0.44	-0.59×	-0.84×	19.1×	-0.77×	82.8%	46.5%	-4744.3%	-4416.2%	193.9%	-2357.6%	-191.9%	-0.94×	-0.35×	-236.86×	0.38×	0.0%	3	-41.23	2	C
Peer median	—	-5.76×	3.47×	42.66×	-5.49×	-101.4%	87.3%	-776.0%	-739.4%	-40.6%	-74.0%	-18.2%	0.07×	0.34×	-22.82×	8.88×	0.0%	2	-11.09	1	—